SOUTH SAN FRANCISCO, Calif., Jan. 4, 2018 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that Raul Rodriguez, the company’s president and chief executive officer, will present an update on its product pipeline and a financial overview at the upcoming 36th&nb…
